 <h1>Congratulations! 🎉 </h1>
    <p style="color:#637381;">All done! You’ve completed another milestone.</p>

To continue, enter your details to log in.

We’ve sent a 6‑digit code to #MAIL_ADDRESS#\nPlease check your inbox or spam folder and enter the code below to continue.

Verification code sent

Thank you for the payment. You can now access {collectionName} by simply clicking the button below.

Yes, you’ve successfully ordered! 🎉

Unlock This Exclusive Course

It seems that your email address is not currently on the authorized access list. Please ensure you are using the email address that was invited, or contact the content owner for assistance.

Verification Required for Access

Foundations of the Intrinsic and Common Pathways

The Normal Intrinsic Pathway: Factors, Activation Sequence, and Regulation for Medical Learners

Clinical Presentations of Intrinsic Pathway Defects

Hemophilia in General: Patterns of Bleeding and Severity Classification for Healthcare Learners

Hemophilia A: Factor VIII Deficiency—Etiology, Pathophysiology, and Diagnosis

Hemophilia B: Factor IX Deficiency—Key Distinctions for Medical Students

Acquired and Rare Intrinsic Pathway Abnormalities

Acquired Factor VIII or IX Inhibitors: Recognition and Initial Workup for Healthcare Learners

Contact Factor Deficiencies and Lupus Anticoagulant: Prolonged aPTT with Minimal Bleeding

Common Pathway Defects and Integrated Coagulation Testing

Link to the Common Pathway: Factors X, V, II, and Fibrinogen—Patterns and Pitfalls

CASE HISTORY Part I: Localizing an Intrinsic Pathway Defect Using PT, aPTT, and Mixing Studies

CASE HISTORY Part 2: Distinguishing Common Pathway and Inhibitor Phenotypes

Assessment: Quizzes and Learner Feedback

Quiz 1: Intrinsic Pathway Core Concepts

Quiz 2: Hemophilia A—Diagnosis and Lab Interpretation

Quiz 3: Hemophilia B—Clinical Distinctions and Testing

Quiz 4: Mixing Studies and Inhibitors

Quiz 5: Contact Factors and Lupus Anticoagulant Patterns

Quiz 6: Common Pathway and Fibrinogen Testing

Quiz 7: Integrated Case-Based Localization

Survey 1: Confidence in Interpreting Coagulation Tests

Survey 2: Course Relevance to Clinical Practice

Diagnosing Intrinsic and Common Pathway Defects: Patterns to Practice is a focused, case-driven course that helps healthcare learners quickly localize coagulation abnormalities using PT, aPTT, mixing studies, and targeted factor assays. Starting with the foundations of the intrinsic pathway (factors XII, XI, IX, VIII and contact factors), you’ll learn cascade logic, the tenase and prothrombinase complexes, physiologic regulation, and how these translate to real laboratory signatures. You’ll then apply pattern recognition to classic and tricky presentations, from hemarthroses in hemophilia A and B to acquired factor inhibitors and lupus anticoagulant. The course also integrates common pathway evaluation—factors X, V, II, and fibrinogen—with practical algorithms that distinguish congenital from acquired causes such as liver disease, vitamin K antagonism, and DIC. Short, high-yield modules are paired with case histories and quizzes that mirror on-call scenarios: isolated prolonged aPTT, dual prolongation of PT/aPTT, discordant mixing studies, and fibrinogen pitfalls. By the end, you’ll be able to move from abnormal screening tests to a confident, evidence-based differential and initial management pathway. This course is ideal preparation for wards, hematology consults, and exam settings where fast, accurate interpretation of coagulation tests makes the difference in patient care.

Diagnosing Intrinsic and Common Pathway Defects: Patterns to Practice

<div class="simple-box-wrapper">
    <div class="simple-box">
        <div class="column">
            <p>Diagnosing Intrinsic and Common Pathway Defects: Patterns to Practice equips medical learners with the conceptual frameworks and practical tools needed to localize coagulation abnormalities rapidly and accurately. We begin by grounding you in the physiology of the intrinsic pathway—factors XII, XI, IX, and VIII, the roles of prekallikrein and HMW kininogen as contact factors, calcium dependence, and the formation of the tenase complex—before linking these steps to the common pathway and thrombin generation. Alongside mechanism, we emphasize physiologic regulation by antithrombin, the protein C system, and TFPI cross-talk, then translate these concepts into laboratory anchors: how aPTT and PT probe different steps, why contact factor defects can markedly prolong aPTT without bleeding, and how amplification logic explains clinical severity. Throughout, the course trains pattern recognition—using PT, aPTT, thrombin time, reptilase time, and mixing studies—to move from screening tests to definitive factor assays with confidence.</p>
<p>Clinical modules focus on the presentations you will encounter: hemophilia in general and the specific nuances of Hemophilia A (factor VIII deficiency) and Hemophilia B (factor IX deficiency). You will learn how bleeding phenotypes (hemarthroses, deep muscle hematomas, delayed bleeding) differ from mucocutaneous patterns, how factor activity levels define severity and guide peri-procedural planning, and how genetics informs inhibitor risk and counseling. The course also tackles acquired and rare abnormalities—time- and temperature-dependent inhibitors to VIII/IX, lupus anticoagulant with its paradox of thrombosis and prolonged aPTT, and contact factor deficiencies that alarm the lab but spare the patient—providing testing algorithms to avoid misinterpretation and unnecessary transfusion. Finally, integrated case histories simulate real-world decision-making, contrasting isolated aPTT prolongation with combined PT/aPTT abnormalities, and applying algorithmic localization from preanalytical checks through factor assays. Targeted quizzes reinforce each step so that by the end you can interpret coagulation tests decisively and manage next actions in practice.</p>
        </div>
    </div>
</div>
